Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients
Status:
Unknown status
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The current treatment methods of liver cirrhosis are limited ,including antiviral
therapy,supportive therapy and liver transplantation. Antiviral therapy and Supportive
therapy especially the regularly intravenous infusions of plasma or albumin are combined in
the clinical classical therapy treatment. In the other hand,umbilical cord mesenchyma stem
cell with self and directed differentiation capacity can effectively rescue experimental
liver failure and contribute to liver regeneration, which suggests the feasibility of stem
cell transplantation therapy. In this study, the safety and efficacy of umbilical cord
mesenchyma stem cell transplantation through interventional procedures and classical therapy
in patients liver cirrhosis will be evaluated and compared.